Potassium phosphate

What it is used for

Potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated.

Side effects, and when to stop

The following clinically significant adverse reactions are described elsewhere in the labeling:

• Hypomagnesemia
• Vein Damage and Thrombosis

The following adverse reactions in Table 3 have been reported in clinical studies or post-marketing reports in patients receiving intravenously administered potassium phosphates. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

TABLE 3: Adverse Reactions Reported in Clinical Studies or Post-marketing Reports with Intravenous Potassium Phosphates

Who should not take it

Potassium Phosphates in Sodium Chloride Injection is contraindicated in patients with:

• hyperkalemia
• hyperphosphatemia
• hypercalcemia or significant hypocalcemia
• severe renal impairment (eGFR less than 30 mL/min/1.73m 2 ) or end stage renal disease